Aidoc gains FDA clearance for AI solution that detects suspected ICH cases, alerts radiologists
Aidoc, a Tel-Aviv, Israel-based medical imaging company, announced Wednesday, August 8, that it has gained FDA clearance for its brain solution that helps radiologists flag acute intracranial hemorrhage (ICH) cases using artificial intelligence (AI). It is the market’s first deep learning solution that assists radiologists directly with workflow triage.
The solution examines head CT exams immediately after the patient is scanned, alerting the radiologist when it detects a potential ICH.
“In a recent clinical study we ran, Aidoc’s brain package demonstrated its potential to substantially reduce report turnaround time and increase the radiologist’s confidence” Barry D. Pressman, MD, chairman of imaging at Cedars-Sinai Medical Center in Los Angeles, said in a prepared statement. “Seeing the software in action emphasized the key aspects an AI solution needs to possess to have an impact on the radiologist day to day—seamless integration into the workflow and broad applicability.”
"Radiologists are challenged with responding to large numbers of acute cases in a timely fashion,” Elad Walach, Aidoc’s CEO, said in the same statement. “The key, we believe, is to be comprehensive. If you really want to impact the daily practice you have to cover a significant portion of the radiologist’s workflow. Our solution can sift through the whole worklist in the background and highlight cases that require immediate attention, improving radiologist’s response time.”
Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.